Antioxidant Enzyme Activity and Cognition in Obese Individuals with or without Metabolic Risk Factors

Abstract

Background: The metabolic syndrome may be associated with cognitive impairment and increased oxidative stress.

Aim: To document the association between metabolic syndrome, cognitive impairment and oxidative stress activity in metabolically healthy obese and in metabolically unhealthy obese individuals.

Methods: 60 obese individuals aged (49±10 years, 52% male) were enrolled. Obesity was defined as BMI>30. Metabolic syndrome was defined according to ATP III guidelines. Obese individuals were divided into 2 groups: Group 1, metabolically healthy obese (≤2 components of metabolic syndrome), and Group 2, metabolically unhealthy obese (>2 components of metabolic syndrome). Cognitive dysfunction was determined by Montreal cognitive assessment score. Liver Fibro scan (Elastography), Inflammation (CRP), pro oxidants (MDA), antioxidant activity (SOD, PON, GSH, GPx) and insulin resistance (HOMA-IR) were measured.

Results: Of the 30 metabolically unhealthy obese individuals, 13% developed dementia, 51% had mild cognitive impairment, and 36% had a normal cognitive score. In the metabolically healthy obese group, 3% developed dementia, 7% had mild cognitive impairment, and 90% had a normal cognitive score. There was a significant difference in liver stiffness (7±3 vs. 5.2±2.7 kpa, p<0.001), liver fat measurement (337±51 vs. 280±20 db/m, p<0.001), MDA (4.7±0.9 vs. 5.47±1.12 mM, P<0.003), Glutathione GSH (27.2±2.4 vs. 28.4±2.3, P<0.03), CRP (9±6 vs. 7±6 P<0.001) and insulin resistance (2.5±1 vs. 6±5.5 p<0.02) between the 2 groups. Correlations were significant between GPx activity and liver stiffness (r=0.37), GPx activity and abdominal girth (r=−0.22) and glucose concentration and SOD activity (r=0.4). Multivariate analysis showed that HOMA-IR, MDA and GSH were the most powerful predictors of metabolically unhealthy obesity.

Conclusion: There is a significant mild cognitive impairment and increased oxidative stress activity in the metabolically unhealthy obese. Whether treatment with anti-oxidants improves cognitive dysfunction remains to be determined.

Key words

antioxidant - metabolic syndrome - healthy individuals - unhealthy - cognition - liver fibro scan

• References

• 1 Luppino FS, de Wit LM, Bouvy PF et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220-229
• 2 Istvan J, Zavela K, Weidner G. Bodyweight and psychological distress in NHANES I. Int J Obes Relat Metab Disord 1992; 16: 999-10033
• 3 Crisp AH, McGuiness B. Jolly fat: relation between obesity and psychoneurosis in general population. BMJ 1976; 1: 7-9
• 4 Magnusson PK, Rasmussen F, Lawlor DA et al. Association of body mass index with suicide mortality: a prospective cohort study of more than one million men. Am J Epidemiol 2006; 163: 1-8
• 5 Blüher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 2010; 21: 38-43
• 6 Wildman RP, Muntner P, Reynolds K et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008; 168: 1617-1624
• 7 Kilpeläinen TO, Zillikens MC, Stančákova A et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011; 43: 753-760
• 8 Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643
• 9 Whitlock G, Lewington S, Sherliker P. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096
• 10 Katzmarzyk PT, Janssen I, Ross R et al. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006; 29: 404-409
• 11 Kip KE, Marroquin OC, Kelley DE et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) study. Circulation 2004; 109: 706-713
• 12 Song Y, Manson JE, Meigs JB et al. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007; 100: 1654-1658
• 13 Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-2912
• 14 St-Pierre AC, Cantin B, Mauriège P et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 2005; 172: 1301-1305
• 15 Calori G, Lattuada G, Piemonti L. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011; 34: 210-215
• 16 Arnlöv J, Ingelsson E, Sundström J et al. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121: 230-236
• 17 Higdon JV, Frei B. Obesity and oxidative stress: a direct link to cardiovascular disease?. Arterioscler Thromb Vasc Biol 2003; 23: 365-367
• 18 Akbaraly TN, Kivimäki M, Brunner EJ et al. Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care 2009; 32: 499-504
• 19 Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S et al. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry 2008; 69: 178-182
• 20 Golden SH, Lazo M, Carnethon M et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008; 299: 2751-2759
• 21 Gale CR, Kivimaki M, Lawlor DA et al. Fasting glucose, diagnosis of type 2 diabetes, and depression: the Vietnam experience study. Biological Psychiatry 2010; 67: 189-192
• 22 Kivimäki M, Tabak AG, Batty GD et al. Hyperglycemia, type 2 diabetes, and depressive symptoms: the British Whitehall II study. Diabetes Care 2009; 32: 1867-1869
• 23 Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171-186
• 24 Wong GK, Lam SW, Wong A et al. Comparison of montreal cognitive assessment and mini-mental state examination in evaluating cognitive domain deficit following aneurysmal subarachnoid haemorrhage. PLoS One 2013; 8: e59946
• 25 Koenigsberg HW, Teicher MH, Mitropoulou V et al. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psych Res 2004; 38: 503-511
• 26 Licht CM, Vreeburg SA, van Reedt Dortland AK. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 2010; 95: 2458-2466
• 27 Mancia G, Bousquet P, Elghozi JL et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25: 909-920
• 28 Trzepacz PT, Hochstetler H, Wang S et al. Alzheimer’s Disease Neuroimaging Initiative . Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC Geriatr 2015; 15: 107
• 29 Yaffe K, Kanaya AM, Lindquist K et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242
• 30 Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and Alzheimer disease. Arch Neurol 2007; 64: 93-96
• 31 Vanhanen M, Koivisto K, Moilanen L et al. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006; 67: 843-847
• 32 Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4: 487-499
• 33 Gasparini L, Gouras GK, Wang R et al. Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 2001; 21: 2561-2570
• 34 Jagust W, Harvey D, Mungas D et al. Central obesity and the aging brain. Arch Neurol 2005; 62: 1545-1548
• 35 Dik MG, Jokner C, Comijs HC et al. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007; 30: 2655-2660
• 36 Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity induced oxidative stress in humans. International journal of obesity 2006; 30: 400-418